Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

851
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
851
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

226
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
226
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

38
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
38
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.1K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

305
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
305

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review of the use of antiretroviral drugs to prevent HIV in neonates and infants.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Association between housing instability and HIV care outcomes among people with HIV in the United States.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Residential mobility and health among people with hiv: a scoping review.

AIDS (London, England)·2026
Same author

Uptake of HIV Self-testing Among Adolescents and Young Adults in Nigeria: A Secondary Observational Analysis of a Stepped-Wedge, Cluster-Randomized Trial.

AIDS and behavior·2026
Same author

Combining Observational Studies to Reduce Multiple Biases.

Epidemiology (Cambridge, Mass.)·2026
Same author

Effectiveness of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy on Risk of Death for Individuals With Cystic Fibrosis.

Chest·2026
Same journal

The Link Between Sleep Health Dimensions and Hypertension for Cardiovascular Health.

Current epidemiology reports·2026
Same journal

Health Information Technology use among healthcare providers treating children and adolescents with obesity: A systematic review.

Current epidemiology reports·2026
Same journal

A Review of Combined Sewer Overflows and Gastrointestinal Illness in a Changing Climate.

Current epidemiology reports·2026
Same journal

Air Pollution Within the Public Health Exposome Framework: Impacts on Cardiovascular Health.

Current epidemiology reports·2026
Same journal

A Narrative Review of Cardiovascular Health in Autistic Individuals: Epidemiologic Evidence, Mechanistic Pathways, and Future Directions.

Current epidemiology reports·2026
Same journal

Transporting: What Is It and How Do You Do It?

Current epidemiology reports·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

Jessie K Edwards1, Laura L Hester1, Mugdha Gokhale1,2

  • 1Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Current Epidemiology Reports
|August 22, 2017
PubMed
Summary
This summary is machine-generated.

Estimating health risks requires accounting for competing events, which can preclude outcomes. This review simplifies risk estimation methods for better pharmacoepidemiologic research and accurate interpretation.

Keywords:
Bias (Epidemiology)Epidemiologic MethodsPharmacoepidemiologySurvival Analysis

More Related Videos

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Feb 24, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

2.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Pharmacoepidemiology

Background:

  • Health outcomes over time are often described by risk.
  • Competing events can preclude the occurrence of health outcomes of interest.
  • Accurate risk estimation is crucial in healthcare and pharmacoepidemiologic research.

Purpose of the Study:

  • To review straightforward approaches for estimating risk in the presence of competing events.
  • To illustrate these methods with examples from pharmacoepidemiologic research.
  • To compare results with commonly used analytic simplifications.

Main Methods:

  • Review of established statistical methods for risk estimation with competing events.
  • Application of methods to real-world pharmacoepidemiologic data.
  • Comparative analysis of different analytical approaches.

Main Results:

  • Straightforward methods for estimating risk in the presence of competing events were presented.
  • Examples demonstrated the application and impact of these methods in pharmacoepidemiology.
  • Differences in results were observed when comparing advanced methods to common simplifications.

Conclusions:

  • The choice of analytical method significantly impacts the interpretation of results in pharmacoepidemiologic studies.
  • Accurate handling of competing events is essential for valid risk estimation.
  • This review provides practical guidance for researchers dealing with competing events.